Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Carcinoma, Adenoid Cystic × Glutamate Carboxypeptidase II × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Salivary Gland Neoplasms 1 Carcinoma, Adenoid Cystic 1

Interventions

pembrolizumab 2 lenvatinib 2 Specimen Handling 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Carboplatin 2 amivantamab 1 Pemetrexed 1 Ipilimumab 1 Glutamate Carboxypeptidase II 1 CTLA-4 Antigen 1 BMS-906024 1 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04895735 2026-02-02

MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer

Mayo Clinic

Phase 2 Active not recruiting

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡